BBOT
BridgeBio Oncology Therapeutics, Inc.
3.90$
-1.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +130.3% | +56,232.9% | +1.3% | +1.3% | +1.1% | -22.9% | +0.9% | +220.5% | -7.5% | -6.9% | -9.8% | |
| – | – | – | -1.6% | -1.6% | -4.5% | +7,148.4% | +0.7% | +234.4% | -10.6% | -37.4% | -9.1% | |
| – | – | – | -1.6% | -1.6% | -4.9% | +1,444.1% | +20.2% | +1,196.8% | -8.6% | -85.9% | +2.7% | |
| – | – | – | -1.6% | -1.6% | -4.9% | +7,893.8% | -3.2% | +256.4% | -9.1% | -40.7% | -10.5% | |
| – | – | – | – | – | – | – | +2,592.5% | -79.0% | +70.8% | -62.2% | – | |
| – | +138.2% | +1,298.2% | +1.0% | +0.8% | +1.1% | +6,030.0% | +8.3% | -89.9% | -2.1% | +21.7% | +18.1% | |
| – | +138.2% | -94.1% | +239.2% | +60.1% | +48.0% | +12,728.8% | +13.3% | +31.0% | -1.9% | +23.5% | +19.4% | |
| – | +61.5% | – | – | – | – | – | +5,233.3% | +58.1% | +3.2% | +3.1% | +3.0% | |
| – | – | – | – | – | – | +18.8% | -39.9% | +66.1% | -62.4% | +779.9% | -44.4% | |
| – | – | – | +1.3% | +1.3% | +1.1% | -206.0% | – | – | -8.0% | -9.4% | -13.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.4% | +14.8% | +0.0% | +0.0% | -99.9% | +2,122.0% | -87.7% | +86,539.1% | +83.9% | -99.9% | +0.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.